Document is current
Any future updates will be listed below
-
Authors
Doeleman, Martijn J. H. http://orcid.org/0000-0003-4786-4108
de Roock, Sytze
Buijsse, Nathan
Klein, Mark
Bonsel, Gouke J.
Seyfert-Margolis, Vicki
Swart, Joost F.
Wulffraat, Nico M.
-
Funding
Funding for this research was provided by:
ReumaNederland (LLP10 (Longstanding Research Support))
-
License Information
Text and Data Mining valid from 2021-03-22
Version of Record valid from 2021-03-22
-
More Information
Article History
Received: 14 August 2020
Accepted: 5 March 2021
First Online: 22 March 2021
Declarations
:
: This study did not fall under the scope of the Medical Research Involving Human Subjects Act, as declared by the locally appointed ethics committee of the University Medical Center Utrecht (reference no. 16-361C).
: Not Applicable.
: VSM is CEO and founder of MyOwnMed, Inc. and has received speaker and/or consulting fees from Conopco Inc. (Unilever), Janssen Research and Development LLC, Kintai Therapeutics Inc., Novartis Pharma AG, Otsuka America Pharmaceutical Inc., and Sanofi US. The other authors have indicated they have no potential conflicts of interest to disclose.
